BriaCell Therapeutics Corp. (BCTX)
4.19
+0.09
(+2.20%)
USD |
NASDAQ |
May 08, 16:00
4.19
0.00 (0.00%)
After-Hours: 20:00
BriaCell Therapeutics EPS Diluted (Quarterly) : -2.577 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | -0.2752 |
| Aurinia Pharmaceuticals, Inc. | 0.2496 |
| Edesa Biotech, Inc. | -0.2819 |
| Xenon Pharmaceuticals, Inc. | -1.171 |
| ProMIS Neurosciences, Inc. | -4.959 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.297M |
| Total Expenses (Quarterly) | 7.222M |
| Enterprise Value | -0.2266M |
| Earnings Yield | -659.3% |
| Normalized Earnings Yield | -672.60 |